LegalJul 1, 2026, 08:32 AM
HCW Biologics Settles $2.8M Disputed Accounts Payable
AI Summary
HCW Biologics Inc. announced the settlement and extinguishment of $2.8 million in disputed accounts payable during the three months ending June 30, 2026. This includes the resolution of a lawsuit and a $1.1 million mechanics' lien with B&I Contractors, Inc. Additionally, the company fully settled its obligations with EirGenix, Inc., reducing manufacturing costs from $1.7 million to $1.2 million through a settlement agreement.
Key Highlights
- HCW Biologics will report a settlement and extinguishment of $2.8 million in disputed accounts payable.
- B&I Contractors, Inc. filed a Voluntary Dismissal with Prejudice, resolving crossclaims against the Company.
- B&I Contractors also filed a Satisfaction of Lien, removing a $1.1 million lien on the Company's property.
- HCW Biologics paid in full amounts owed under a settlement agreement with EirGenix, Inc.
- The EirGenix settlement reduced amounts owed from $1.7 million to $1.2 million.
- Payments to EirGenix included $620,000 on March 3, 2026, and $620,000 on May 26, 2026.
Price Impact
More from HCWB